This laboratory study aimed at evaluating the physicochemical properties and the ability of various glass ionomer cements (GICs) containing experimental fluoride-doped calcium phosphates (FDCP) or zinc-polycarboxylate bioactive glass (BAG-Zn) to induce mineral precipitation in comparison to the commercial GICs. The independent variables in this study were the materials (2 levels: Fuji™ IX GP [IX-GP] and Fuji™ II LC [II-LC]), particle types (2 levels: FDCP and BAG-Zn), and particle concentrations (4 levels: 0, 5, 10, and 20 wt%). Each experimental cement was prepared and molded into disc-shaped specimens and subsequently assessed for pH, Ca 2 + and F - release, and as well as compressive strength after storage in deionized water for 1, 7, and 28 days at 37°C. The mineral formation subsequent phosphate-buffered saline (PBS) storage was performed at baseline and after 28 days via Fourier-transform infrared (FTIR) analysis and a scanning electron microscope/energy-dispersive X-ray (SEM/ EDS). Experimental IX-GP groups showed significantly lower compressive strength without evident ability in CaP-based mineral deposition. In contrast, II-LC incorporated with 10/20 % FDCPs or 5 % BAG-Zn has significantly superior compressive strength, and evident mineral CaP-based deposition on the material’s surfaces. Incorporating 5 % BAG-Zn in II-LC may be a potential strategy to create innovative restorative materials with superior fluoride release and mechanical properties. On the other hand, incorporating 10/20 % FDCPs would generate GICs with lower acidity, higher fluoride-releasing activity, an evident ability to induce mineral CaP-based deposition, and high compressive strength. • II-LC + 5 wt% BAG-Zn increases fluoride release, compressive strength, and CaP deposition. • II-LC + 10–20 wt% FDCP lowers acidity, raises compressive strength, and promotes CaP deposition. • Additives in IX-GP reduced compressive strength; no clear CaP deposition. • FTIR found apatite-like signals in II-LC in PBS when SEM/EDS showed none. • Use SBF to better assess bioactivity and apatite formation in future tests
No takes yet. Share an insight, caveat, or question.
Tsuchiya et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: